Association of atrial fibrillation with mortality and disability after ischemic stroke

Neurology

Volumn 81, Issue 9, 2013, Pages 825-832

  McGrath, Emer R ^a,b   Kapral, Moira K ^c,d   Fang, Jiming ^d   Eikelboom, John W ^e   O'Conghaile, Aengus ^a   Canavan, Michelle ^a   O'Donnell, Martin J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RISK FACTOR; SPEECH THERAPY; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; DISABLED PERSONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME;

EID: 84884470321     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a2cc15     Document Type: Article

References (25)

1. Wolf PA, Mitchell JB, Baker CS, KannelWB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998;158:229-234.
2. Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996; 27:1760-1764.
3. Appelros P, Nydevik I, Seiger A, Terent A. Predictors of severe stroke: influence of preexisting dementia and cardiac disorders. Stroke 2002;33:2357-2362.
4. Kimura K, Minematsu K, Yamaguchi T. Atrial fibrillation as a predictive factor for severe stroke and early death in 15, 831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005;76:679-683.
5. Steger C, Pratter A, Martinek-Bregel M, et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke Registry. Eur Heart J 2004;25:1734-1740.
6. Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke 2001;32:392-398.
7. KapralMK, Silver FL, Richards JA. Registry of the Canadian Stroke Network. Progress Report 2001-2005. Toronto: Institute for Clinical Evaluative Sciences; 2005.
8. Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke 2009;40:3393-3395.
9. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials-a literature review and synthesis. Stroke 2007; 38:1091-1096.
10. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 2004;164:1761-1768.
11. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-1026.
12. Smith EE, Shobha N, Dai D, et al. Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With The Guidelines Stroke Program. Circulation 2010;122:1496-1504.
13. Bushnell CD, Johnston DC, Goldstein LB. Retrospective assessment of initial stroke severity: comparison of the NIH Stroke Scale and the Canadian Neurological Scale. Stroke 2001;32:656-660.
14. Cote R, Hachinski V, Shurvell B, Norris J, Wolfson C. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke 1986;17:731-737.
15. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian Neurological Scale: validation and reliability assessment. Neurology 1989;39: 638-643.
16. Nilanont Y, Komoltri C, Saposnik G, et al. The Canadian Neurological Scale and the NIHSS: development and validation of a simple conversion model. Cerebrovasc Dis 2010;30:120-126.
17. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE Study): a case-control study. Lancet 2010;376:112-123.
18. McGrath ER, Kapral MK, Fang J, et al. Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation? Stroke 2012;43:2048-2054.
19. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Acute stroke with atrial fibrillation: The Copenhagen Stroke Study. Stroke 1996;27:1765-1769.
20. O'Donnell M, Oczkowski W, Fang J, et al. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol 2006;5:749-754.
21. Engelter ST, Gostynski M, Papa S, et al. Epidemiology of aphasia attributable to first ischemic stroke: incidence, severity, fluency, etiology, and thrombolysis. Stroke 2006;37:1379-1384.
22. Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000;355:1205-1210.
23. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation. Europace 2007;9: 1006-1023.
24. Hall R, Khan F, O'Callaghan C, et al. Ontario Stroke Evaluation Report 2012: Prescribing System Solutions to Improve Stroke Outcomes. Toronto: Institute for Clinical Evaluative Sciences; 2012.
25. Rosenbaum P, Rubin D. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984;79:516-524.